Target Name: LPP
NCBI ID: G4026
Review Report on LPP Target / Biomarker Content of Review Report on LPP Target / Biomarker
LPP
Other Name(s): Lipoma-preferred partner (isoform a) | LIM protein | lipoma preferred partner | LIM domain containing preferred translocation partner in lipoma , transcript variant 2 | LPP variant 1 | LIM domain containing preferred translocation partner in lipoma | LIM domain-containing preferred translocation partner in lipoma | LPP_HUMAN | LIM domain containing preferred translocation partner in lipoma, transcript variant 1 | LPP variant 2 | Lipoma-preferred partner

LPP: A Protein Implicated in Cell-Cell Adhesion and Cancer Progression

Lipoma-Preferred Partner (ISOform A), also known as LPP, is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell-cell adhesion and has been implicated in a number of diseases, including cancer. In recent years, researchers have been interested in using LPP as a drug target or biomarker.

One of the main functions of LPP is its role in cell-cell adhesion. This is the process by which cells stick together to form tissues and organs. LPP helps to regulate the formation of tight junctions, which are the weakest type of cell-cell adhesion, and also plays a role in the maintenance of cell-cell adhesion in the brain.

LPP has also been shown to be involved in a number of signaling pathways that are important for cancer progression. For example, LPP has been shown to be involved in the regulation of theNotch signaling pathway, which is a well-known pathway that promotes the development of cancer.

In addition to its role in cell-cell adhesion and cancer progression, LPP has also been shown to be involved in a number of other biological processes that are important for human health. For example, LPP has been shown to be involved in the regulation of inflammation, and has been linked to the development of autoimmune diseases.

Despite the potential for LPP as a drug target or biomarker, much research is still needed to fully understand its role in these processes. In addition, the use of LPP as a drug target or biomarker is still in its early stages, and much more research is needed to determine its safety and effectiveness.

In conclusion, LPP is a protein that is expressed in various tissues throughout the body and is involved in a number of important biological processes. As a result, it is of interest as a drug target or biomarker. Further research is needed to fully understand its role in these processes and to determine its safety and effectiveness as a drug.

Protein Name: LIM Domain Containing Preferred Translocation Partner In Lipoma

Functions: May play a structural role at sites of cell adhesion in maintaining cell shape and motility. In addition to these structural functions, it may also be implicated in signaling events and activation of gene transcription. May be involved in signal transduction from cell adhesion sites to the nucleus allowing successful integration of signals arising from soluble factors and cell-cell adhesion sites. Also suggested to serve as a scaffold protein upon which distinct protein complexes are assembled in the cytoplasm and in the nucleus

The "LPP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LPP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LPP-AS1 | LPP-AS2 | LPXN | LRAT | LRATD1 | LRATD2 | LRBA | LRCH1 | LRCH2 | LRCH3 | LRCH4 | LRCOL1 | LRFN1 | LRFN2 | LRFN3 | LRFN4 | LRFN5 | LRG1 | LRGUK | LRIF1 | LRIG1 | LRIG2 | LRIG2-DT | LRIG3 | LRIG3-DT | LRIT1 | LRIT2 | LRIT3 | LRMDA | LRP1 | LRP10 | LRP11 | LRP12 | LRP1B | LRP2 | LRP2BP | LRP3 | LRP4 | LRP4-AS1 | LRP5 | LRP5L | LRP6 | LRP8 | LRPAP1 | LRPPRC | LRR1 | LRRC1 | LRRC10 | LRRC10B | LRRC14 | LRRC14B | LRRC15 | LRRC17 | LRRC18 | LRRC19 | LRRC2 | LRRC2-AS1 | LRRC20 | LRRC23 | LRRC24 | LRRC25 | LRRC26 | LRRC27 | LRRC28 | LRRC3 | LRRC30 | LRRC31 | LRRC32 | LRRC34 | LRRC36 | LRRC37A | LRRC37A11P | LRRC37A14P | LRRC37A15P | LRRC37A16P | LRRC37A17P | LRRC37A2 | LRRC37A3 | LRRC37A4P | LRRC37A5P | LRRC37A6P | LRRC37A7P | LRRC37A9P | LRRC37B | LRRC37BP1 | LRRC38 | LRRC39 | LRRC3B | LRRC3C | LRRC4 | LRRC40 | LRRC41 | LRRC42 | LRRC43 | LRRC45 | LRRC46 | LRRC47 | LRRC49 | LRRC4B | LRRC4C